No effect of a selective serotonergic/noradrenergic reuptake inhibitor on endurance performance

European Journal of Sport Science

Volumn 2, Issue 6, 2002, Pages 1-10

  Piacentini, Maria Francesca ^a,b   Meeusen, Romain ^a   Buyse, Luk ^a   de Schutter, Guy ^a   de Meirleir, Kenny ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF ROME FORO ITALICO   (Italy)

Author keywords

Brain neurotransmission; Central fatigue; Exercise; HPA axis

Indexed keywords

EID: 0042034765     PISSN: 17461391     EISSN: 15367290     Source Type: Journal    
DOI: 10.1080/17461391.2002.10142578     Document Type: Article

References (36)

1. Acworth I, Nicolass J, Morgan B, Newsholme EA. 1986. Effect of sustained exercise on concentrations of plasma aromatic and branched chain amino acids and brain amines. Biochem Biophys Res Comm 137:149-53.
2. Andelmawla AH, Langley RW, Szabadi E, Bradshaw CM. 1999. Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine- evoked constriction of the dorsal hand vein. Br J Clin Pharmacol 48:345-54.
3. Arcelin R, Delignières D, Brisswalter J. 1998 Selective effects of physical exercise on choice reaction processes. Percept Mot Skills 87:175-85.
4. Bailey S, Davis J, Ahlborn E. 1992. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol Scand 145:75-76.
5. Bailey S, Davis J, Ahlborn E. 1993a. Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. J Appl Physiol 74:3006-12.
6. Bailey S, Davis J, Ahlborn E. 1993b. Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med 14:330-33.
7. Barchas JD, Freedman DX. 1963. Brain amines: response to physiological stress. Biochem Pharmacol 12:1232-35.
8. Beïque JC, de Montigny C, Blier P, Debonnel G. 1998. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine. Br J Pharmacol 125:526-32.
9. Beïque JC, de Montigny C, Blier P, Debonnel G. 1999. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Synapse 32:198-211.
10. Bitsosis P, Szabadi E, Bradshaw CM. 1999. Comparison of the effects of venlafaxine, paroxetine and desipramine on the pupillary light reflex in man. Psychopharmacol 143:286-92.
11. Blomstrand E, Celsing F, Newsholme EA. 1988. Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol Scand 133:115-21.
12. Borg G. 1980. A category scale with ratio proprieties for intemodal and interindividual comparisons. In: Proceedings of the 22nd international Congress of Psychology. Leipzig: VEB Deutscher Verlag.
13. Chaouloff F. 1993. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18:1-32.
14. Cleare AJ, Forsling M, Bond AJ. 1998. Neuroendocrine and hypothermic effects of 5- HT1A receptor stimulation with ipsapirone in healthy men: a placebo controlled study. Int Clin Psychopharmacol 13:23-32.
15. Davis M, Bailey S, Jackson D. 1993. Effects of a serotonin agonist during prolonged exercise to fatigue in humans. Med Sci Sports Exerc 25(5):S78.
16. Davis MJ, Bailey SP. 1997. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 29(1):45-57.
17. Dawson LA, Nguyen HQ, Geiger A. 1999. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5- HT1A receptor antagonism. Neuropharmacol 38:1153-63.
18. Engler D, Redei E, Kola I. 1999. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulartory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocrine Rev 20:460-500.
19. Fery T, Ferry A, Von Hoffe A. 1997. Effect of physical exhaustion on cognitive functioning. Percept Mot Skills 84:291-98.
20. Gerlo E, Malfait R. 1985. High-performance liquid chromatographic assay of free norepinephrine, epinephrine, dopamine, vanillylmandelic acid and homovanillic acid. J Chromatogr 343:9-20.
21. Gur E, Dremencov E, Lerer B, Newman ME. 1999. Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. Eur J Pharmacol 372:17-24.
22. Meeusen R, De Meirleir K. 1995. Exercise and brain neurotransmission. Sports Med 20(3):160-88.
23. Meeusen R, Piacentini MF, De Meirleir K. 2001. Brain microdialysis in exercise research. Sports Med 31:965-83.
24. Meeusen R, Roeykens J, Magnus L, Keizer H, De Meirleir K. 1997. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/ 2C) antagonist. Int J Sports Med 18:571-77.
25. Meeusen R, Smolders I, Sarre S, De Meirleir K, Keizer H, Serneels M, Ebinger G, Michotte Y. 1997. Endurance training effects on neurotransmitter release in rat striatum: an in vivo microdialysis study. Acta Physiol Scand 159:335-41.
26. Meeusen R, Thorré K, Chaouloff F, Sarre S, De Meirleir K, Ebinger G, Michotte Y. 1996. Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food deprived rats. Brain Res 740:245-52.
27. Meeusen, R, Piacentini MF, Van Den Eynde S, Magnus L, De Meirleir K. 2001. Exercise performance is not influenced by a 5-HT reuptake inhibitor. Int J Sports Med 22:329-36.
28. Montgomery, SA. 1997. Is there a role for pure noradrenergic drug in the treatment of depression? Eur Neuropsychopharmacol 7:S3-S9.
29. Newsholme EA, Acworth I, Blomstrand E. 1987. Amino acids, brain neurotransmitters and a functional link between muscle and brain that is important in sustained exercise. In: Benzi G, editor. Advances in myochemistry. London: John Libby Eurotext. p. 127-38.
30. Piacentini MF, Meeusen R, Buyse L, De Schutter G, Kempenaers F, Van Nijvel J, De Meirleir K. 2002. No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc 34:1189-93.
31. Porter RJ, McAllister-Williams RH, Young AH. 1999. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers. Psychopharmacol 146:194- 98.
32. Redrobe JP, Bourin M, Colomberl MC, Baker GB. 1998. Dose-dependent noradrenergic and serotonergic proprieties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacol 138:1-8.
33. Struder H, Weicker H. 2001. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part I. Int J Sports Med 22:467-81.
34. Struder H, Weicker H. 2001. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part II. Int J Sports Med 22:482-97.
35. Struder HK, Hollman W, Platen P, Duperly J, Fischer HG, Weber K. 1998. Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res 30(4):188-94.
36. Wilson W, Maughan R. 1992 Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exper Physiol 77:921-24.